✦ LIBER ✦

Reliability of symptom onset assessment in Parkinson's disease

✍ Scribed by M. Richards; K. Marder; L. Cote; Dr. R. Mayeux

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 234 KB
Volume: 9
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870090313

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Test‐retest reliability of onset date and type of initial symptoms of Parkinson's disease (PD) was assessed in 45 patients with PD who were drawn from a community‐dwelling cohort in New York City. Patients were the sole information providers on both rating occasions. Reliability of symptom‐onset data was found to be high, even when the interval between test and retest was up to 3 years and when the information was elicited by different neurologists. However, these patients were less consistent about the type of early symptoms. When interpreting their own disease history, patients with PD may attach more importance to when their disease began than to how it began.

📜 SIMILAR VOLUMES

Reliability of reported age at onset for

Reliability of reported age at onset for Parkinson's disease

✍ Carson R. Reider; Cheryl A. Halter; Peter F. Castelluccio; David Oakes; William 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

## Abstract An individual's age at onset of Parkinson disease (PD) can be collected through a variety of sources, including medical records, family report, and clinical observation. The most common source of PD age at onset information in the research setting is family‐report, which is then typical

Mood, side of motor symptom onset and pa

Mood, side of motor symptom onset and pain complaints in Parkinson's disease

✍ Patrick McNamara; Karina Stavitsky; Erica Harris; Orsolya Szent-Imrey; Raymon Du 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract ## Objective Patients with Parkinson's disease (PD) present with a variety of non‐motor symptoms including sensory complaints and mood disturbances. In the current pilot study, we aimed to explore pain complaints and the association between mood and pain in PD. We hypothesized that pai

Onset and spread of dyskinesias and moto

Onset and spread of dyskinesias and motor symptoms in Parkinson's disease

✍ Giovanni Fabbrini; Giovanni Defazio; Carlo Colosimo; Antonio Suppa; Maria Bloise 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

## Abstract We retrospectively investigated in consecutive Parkinson's disease (PD) outpatients the relationship between the body region in which LID first appeared and the body region where Parkinsonian motor symptoms started. We also studied the spread of LID and motor symptoms to other body part

Laryngeal dystonia as a presenting sympt

Laryngeal dystonia as a presenting symptom of young-onset Parkinson's disease

✍ Spiridon Papapetropoulos; Donna S. Lundy; Roy R. Casiano; Carlos Singer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 1 views

Echocardiogram revealed diffuse hypokinesis, dilatation of left ventricular cavity, and thinning of left ventricular wall. Ejection fraction was decreased to 49%. Cardiac muscle biopsy demonstrated hypertrophied cardiomyocyte and interstitial fibrosis of left ventricle. A gastrocnemius muscle biopsy

Neuropsychiatric symptoms in Parkinson's

Neuropsychiatric symptoms in Parkinson's disease

✍ Dag Aarsland; Laura Marsh; Anette Schrag 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract Neuropsychiatric symptoms are common in Parkinson's disease, even at the earliest stages, and have important consequences for quality of life and daily functioning, are associated with increased carer burden and increased risk for nursing home admission. In addition to cognitive impairm

Neuropsychiatric symptoms in Parkinson's

Neuropsychiatric symptoms in Parkinson's disease

✍ Joseph Friedman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 1 views

In their excellent review of neuropsychiatric problems in Parkinson's disease (PD), 1 the authors made one small error but more importantly raised an interesting question about drug trials. Also, as they wrote their article, both melperone (personal communication) and pimavanserin, 2 subjected to ra